Advanced search
Publication Cover
Ophthalmic Epidemiology Volume 23, 2016 - Issue 4
Submit an article Journal homepage
510
Views
10
CrossRef citations to date
0
Altmetric
Original Articles

Burden of Wet Age-Related Macular Degeneration and Its Economic Implications in Singapore in the Year 2030

Nakul SaxenaDepartment of Health Services and Outcomes Research, National Healthcare Group, SingaporeCorrespondence[email protected] [email protected]
,
Pradeep Paul GeorgeDepartment of Health Services and Outcomes Research, National Healthcare Group, Singapore
,
Heng Bee HoonDepartment of Health Services and Outcomes Research, National Healthcare Group, Singapore
,
Lim Tock HanDepartment of Ophthalmology, Tan Tock Seng Hospital, Singapore
&
Yong Shao OnnDepartment of Ophthalmology, Tan Tock Seng Hospital, Singapore
Pages 232-237 | Received 06 Sep 2015, Accepted 15 Feb 2016, Published online: 24 Jun 2016

References

  • Mitchell P, et al. Prevalence of age-related maculopathy in Australia. The Blue Mountains Eye Study. Ophthalmology 1995;102:1450–1460.
  • Cheung CM, et al. Prevalence of and risk factors for age-related macular degeneration in a multiethnic Asian cohort. Arch Ophthalmol 2012;130:480–486.
  • Wong TY, Loon SC, Saw SM. The epidemiology of age related eye diseases in Asia. Br J Ophthalmol 2006;90:506–511.
  • Resnikoff S, et al. Global data on visual impairment in the year 2002. Bull World Health Organ 2004;82:844–851.
  • Varma R, et al. Prevalence of age-related macular degeneration in Latinos: the Los Angeles Latino eye study. Ophthalmology 2004;111:1288–1297.
  • Pascolini D, Mariotti SP. Global estimates of visual impairment: 2010. Br J Ophthalmol 2012;96:614–618.
  • Wong WL, et al. Global prevalence of age-related macular degeneration and disease burden projection for 2020 and 2040: a systematic review and meta-analysis. Lancet Global Health 2014;2:e106–e116.
  • Wagle AM. A decade of progress in the understanding, prevention and treatment of age-related macular degeneration in Singapore. Ann Acad Med Singapore 2015;44:116–118.
  • Au Eong KG. Age-related macular degeneration: an emerging challenge for eye care and public health professionals in the Asia Pacific region. Ann Acad Med Singapore 2006;35:133–135.
  • Woo JH, Au Eong KG. Don’t lose sight of age-related macular degeneration: the need for increased awareness in Singapore. Singapore Med J 2008;49:850–853.
  • Cheung CM, et al. Prevalence, racial variations, and risk factors of age-related macular degeneration in Singaporean Chinese, Indians, and Malays. Ophthalmology 2014;121:1598–1603.
  • Brown GC, et al. The burden of age-related macular degeneration: a value-based medicine analysis. Trans Am Ophthalmol Soc 2005;103:173–184; discussion 184–186.
  • Brown MM, et al. Age-related macular degeneration: economic burden and value-based medicine analysis. Can J Ophthalmol 2005;40:277–287.
  • Dilokthornsakul P, et al. Health resource utilization and the economic burden of patients with wet age-related macular degeneration in Thailand. Int J Ophthalmol 2014;7:145–151.
  • Age-Related Eye Disease Study Research Group. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol 2001;119:1417–1436.
  • Saxena N, et al. Cost-effectiveness of anti-oxidant vitamins plus zinc treatment to prevent the progression of intermediate age-related macular degeneration. A Singapore perspective. Indian J Ophthalmol 2015;63:516–523.
  • Rein DB, et al. The economic burden of major adult visual disorders in the United States. Arch Ophthalmol 2006;124:1754–1760.
  • Garattini L, et al. Direct medical costs of age-related macular degeneration in Italian hospital ophthalmology departments. A multicenter, prospective 1-year study. Eur J Health Econ 2004;5:22–27.
  • Lindekleiv H, Erke MG. Projected prevalence of age-related macular degeneration in Scandinavia 2012–2040. Acta Ophthalmol 2013;91:307–311.
  • Jo C. Cost-of-illness studies: concepts, scopes, and methods. Clin Mol Hepatol 2014;20:327–337.
  • United Nations, Department of Economic and Social Affairs, Population Division, Population Estimates and Projections Section. United Nations Population Estimates. Accessed July 2015 from: http://esa.un.org/wpp/Excel-Data/population.htm
  • Department of Statistics, Singapore. Accessed October 10, 2015 from: http://www.singstat.gov.sg/
  • Chew EY, et al. Long-term effects of vitamins C and E, beta-carotene, and zinc on age-related macular degeneration: AREDS Report No. 35. Ophthalmology 2013;120:1604–1611.e4.
  • Patel JJ, et al. Cost-utility analysis of bevacizumab versus ranibizumab in neovascular age-related macular degeneration using a Markov model. J Eval Clin Pract 2012;18:247–255.
  • Heier JS, et al. Intravitreal aflibercept (VEGF Trap-Eye) in wet age-related macular degeneration. Ophthalmology 2012;119:2537–2548.
  • Durand-Zaleski I. Why cost-of-illness studies are important and inform policy. Vasc Med 2008;13:251–253.
  • Rein DB, et al. Forecasting age-related macular degeneration through the year 2050: the potential impact of new treatments. Arch Ophthalmol 2009;127:533–540.
  • Kawasaki R, et al. The prevalence of age-related macular degeneration in Asians: a systematic review and meta-analysis. Ophthalmology 2010;117:921–927.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.